Navam Capital

Vayudh's aim is to create next-generation nanodrones and swarming technologies for modern defense and security applications.

GalaxEye is a provider of satellite-based imaging services that specializes in earth observation through the use of multi-sensor imaging satellites. The company offers high-frequency data coverage with enhanced spatial and temporal resolution, allowing businesses in both the government and commercial sectors to make informed decisions and operate more efficiently. By leveraging advanced space technology, GalaxEye aims to transform how organizations utilize satellite data to improve their operational capabilities.

Alyssum Therapeutics is a biotechnology company dedicated to developing advanced immunotherapies that target B cells for cancer treatment. The company specializes in supramolecular therapeutics, which are designed to serve as innovative solutions for various cancers, including lung, testicular, colorectal, and childhood cancers. Alyssum Therapeutics employs supramolecular technology to create antibody drugs that specifically engage with tumors and modulate the immune response. This approach allows oncologists to effectively activate the immune system and combat cancer cells, aiming to enhance treatment outcomes for patients.

Aereo, formerly known as Aarav Unmanned Systems, is a leading drone manufacturing and solutions company based in Bangalore, India, founded in 2013 at IIT Kanpur. The company specializes in providing end-to-end drone technology solutions tailored for various sectors, including urban and rural development, agriculture, mining, construction, irrigation, forest conservation, renewable energy, and infrastructure development. Aereo's drones are designed to enhance productivity and data quality, offering advanced business intelligence that aids in critical decision-making. The firm has achieved significant milestones, including mapping over 34,000 villages and impacting the lives of over 45 million individuals. Notably, Aereo was the first to launch India’s DGCA-certified survey-grade PPK drone. Their technology includes a proprietary 3-dimensional web-GIS that allows for 360-degree visibility and efficient image processing, thereby supporting enterprise stakeholders in managing data more effectively.

Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have been developed at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas. REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings.

TechEagle Innovations is a leading drone logistics company focused on transforming last-mile delivery through advanced, temperature-controlled solutions tailored for healthcare, e-commerce, and essential goods. The company specializes in the development of hybrid drones and autonomous fleet management systems, utilizing proprietary technology to facilitate long-range operations and adaptable payloads. TechEagle’s innovative drones are designed to handle critical deliveries, including medicines, vaccines, and perishables, ensuring reliability even in challenging environments. With regulatory approvals for operations in restricted airspaces, the company has established itself as a leader in the drone logistics sector. Its comprehensive ecosystem encompasses autonomous drones, cloud-based fleet management software, and Unmanned Aircraft System Traffic Management systems, enhancing supply chain efficiency across various sectors. Headquartered in India, TechEagle has successfully partnered with organizations such as AIIMS and India Post, showcasing its capabilities in both urban and remote areas. Recognized for its impactful innovations, TechEagle is set to redefine logistics through its advanced drone delivery networks on a global scale.

Fasal, developed by Wolkus Technology Solutions, is an agri-tech platform that leverages artificial intelligence to enhance the agricultural ecosystem. It records various growing conditions on farms and employs data science to make accurate predictions regarding on-farm practices. The platform delivers insights across multiple devices, including iOS, Android, tablets, and web interfaces, ensuring accessibility for users. Fasal's precision agriculture solutions provide real-time agronomic recommendations based on data collected from agnostic sensors, which monitor on-farm and micro-climate conditions. By offering detailed, crop-specific intelligence—including predictive weather information and pest management strategies—Fasal helps farmers optimize their resources, resulting in significant cost savings on water, energy, fertilizers, and pesticides while increasing overall harvest yields.

Ather Energy is an Indian manufacturer of electric scooters and an electric vehicle charging network known as AtherGrid. The company aims to create a comprehensive ecosystem for electric mobility in India, focusing on indigenous design and local manufacturing. Its flagship product, the Ather 450X, is recognized for its powerful performance, long-range, and advanced features such as a touchscreen dashboard and connected mobile apps. The Ather 450 Plus offers similar innovations with a balance of performance and affordability. Both models are equipped with a smart dashboard that provides navigation, ride statistics, and features accessible via mobile applications, allowing users to monitor their vehicle's performance and locate charging points. Ather Energy's vehicles are powered by lithium-ion battery packs with integrated digital battery management systems, promoting a safer and cleaner mode of transportation.

Tvasta is a company focused on advancing manufacturing and automation technologies, with a particular emphasis on 3D printing. It aims to revolutionize product development and delivery across various sectors, including construction, automotive, aerospace, and medical industries. Tvasta designs innovative 3D printers capable of working with diverse materials such as concrete, metals, polymers, and ceramics. By prioritizing research and development, Tvasta seeks to enhance human productivity and enable deep personalization in its offerings, ultimately providing an integrated end-to-end experience for its customers.

Alyssum Therapeutics is a biotechnology company dedicated to developing advanced immunotherapies that target B cells for cancer treatment. The company specializes in supramolecular therapeutics, which are designed to serve as innovative solutions for various cancers, including lung, testicular, colorectal, and childhood cancers. Alyssum Therapeutics employs supramolecular technology to create antibody drugs that specifically engage with tumors and modulate the immune response. This approach allows oncologists to effectively activate the immune system and combat cancer cells, aiming to enhance treatment outcomes for patients.

Agnikul Cosmos Private Limited is an Indian space technology startup founded in 2017 and based in Chennai, Tamil Nadu. The company specializes in the design, manufacture, testing, and launch of orbital-class rockets specifically tailored for micro and nanosatellites. Operating from the National Center for Combustion R&D at IIT-Madras, Agnikul's team comprises rocket scientists, engineers, ex-bankers, and space lawyers, contributing to a diverse skill set that enhances its capabilities. The company's launch vehicles are fully mobile and can be deployed from various launch ports, utilizing kerosene as fuel. This innovative approach allows for access to both low and high-inclination orbits, providing customers with on-demand access to space at competitive prices.

Orangewood Labs Inc. is a San Francisco-based company that specializes in manufacturing and distributing customized furniture. In addition to its furniture operations, the company is developing robotic arms designed specifically for small businesses. These robots are intended to democratize access to automation in manufacturing, offering solutions that are safe, user-friendly, and affordable. Through its innovative approach, Orangewood Labs aims to address contemporary manufacturing challenges, making advanced robotic technology accessible to a wider range of enterprises.

Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics Inc. is a biopharmaceutical company focused on developing innovative drugs to address antibiotic-resistant acne and other related skin conditions. The company’s portfolio includes several products targeting skin disorders, with its lead molecule, VB 1953, specifically aimed at overcoming challenges in the drug-resistant acne market. In addition to VB 1953, Vyome's offerings encompass DARTS, aimed at preventing antibiotic resistance; VB 001, an anti-dandruff leave-on product; VB 2421, an anti-dandruff hair gel; VB 3222, a wash-off anti-dandruff shampoo; and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics utilizes a robust development platform that emphasizes risk mitigation and a focus on validated targets. The company is equipped with advanced infrastructure for research and development, enabling efficient commercialization of its therapeutic innovations.

Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics Inc. is a biopharmaceutical company focused on developing innovative drugs to address antibiotic-resistant acne and other related skin conditions. The company’s portfolio includes several products targeting skin disorders, with its lead molecule, VB 1953, specifically aimed at overcoming challenges in the drug-resistant acne market. In addition to VB 1953, Vyome's offerings encompass DARTS, aimed at preventing antibiotic resistance; VB 001, an anti-dandruff leave-on product; VB 2421, an anti-dandruff hair gel; VB 3222, a wash-off anti-dandruff shampoo; and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics utilizes a robust development platform that emphasizes risk mitigation and a focus on validated targets. The company is equipped with advanced infrastructure for research and development, enabling efficient commercialization of its therapeutic innovations.

Vyome Therapeutics Inc. is a biopharmaceutical company focused on developing innovative drugs to address antibiotic-resistant acne and other related skin conditions. The company’s portfolio includes several products targeting skin disorders, with its lead molecule, VB 1953, specifically aimed at overcoming challenges in the drug-resistant acne market. In addition to VB 1953, Vyome's offerings encompass DARTS, aimed at preventing antibiotic resistance; VB 001, an anti-dandruff leave-on product; VB 2421, an anti-dandruff hair gel; VB 3222, a wash-off anti-dandruff shampoo; and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics utilizes a robust development platform that emphasizes risk mitigation and a focus on validated targets. The company is equipped with advanced infrastructure for research and development, enabling efficient commercialization of its therapeutic innovations.

EnNatura Technology Ventures (P) Ltd. is a clean materials company based in New Delhi, India, founded in 2006. The company focuses on developing specialty chemicals derived from renewable sources, emphasizing sustainability in its product offerings. EnNatura designs innovative polymers that aim to reduce hydrocarbon consumption, contributing to environmental conservation. Additionally, the company provides a resin platform tailored for applications in the printing ink industry, along with producing eco-friendly printing inks. Through its commitment to clean technology, EnNatura Technology Ventures strives to address the challenges of conventional materials and promote greener alternatives in various industrial sectors.

Frinks AI is an AI Software Development firm offering Effective, Efficient and Reliable Quality Control.